1. Home
  2. GILT vs ATXS Comparison

GILT vs ATXS Comparison

Compare GILT & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gilat Satellite Networks Ltd.

GILT

Gilat Satellite Networks Ltd.

HOLD

Current Price

$12.30

Market Cap

747.5M

Sector

Technology

ML Signal

HOLD

Logo Astria Therapeutics Inc.

ATXS

Astria Therapeutics Inc.

HOLD

Current Price

$12.91

Market Cap

722.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GILT
ATXS
Founded
1987
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
747.5M
722.1M
IPO Year
1993
2015

Fundamental Metrics

Financial Performance
Metric
GILT
ATXS
Price
$12.30
$12.91
Analyst Decision
Strong Buy
Hold
Analyst Count
1
6
Target Price
$16.00
$24.33
AVG Volume (30 Days)
543.1K
1.3M
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
42.22
N/A
EPS
0.41
N/A
Revenue
$392,826,000.00
$706,000.00
Revenue This Year
$49.48
N/A
Revenue Next Year
$13.61
N/A
P/E Ratio
$30.72
N/A
Revenue Growth
29.68
N/A
52 Week Low
$5.30
$3.56
52 Week High
$15.24
$13.29

Technical Indicators

Market Signals
Indicator
GILT
ATXS
Relative Strength Index (RSI) 50.27 63.64
Support Level $11.91 $12.70
Resistance Level $13.08 $13.29
Average True Range (ATR) 0.46 0.22
MACD 0.17 -0.06
Stochastic Oscillator 59.90 61.31

Price Performance

Historical Comparison
GILT
ATXS

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Share on Social Networks: